- Intravenous Administration of Toll-Like Receptor Inhibitory Peptide 1 is Effective for the Treatment of Systemic Lupus Erythematosus in a Mus musculus Model
-
Baek WY, Lee SM, Lee SW, Son IO, Choi S, Suh CH
- KMID: 2516949
- J Rheum Dis.
- 2021 Jul;28(3):133-142.
- doi: 10.4078/jrd.2021.28.3.133
Objective Systemic lupus erythematosus (SLE) is a common chronic autoimmune inflammatory disease. According to recent studies, signaling through Toll-like receptor (TLR) protein, which promotes the production of inflammatory cytokines, leads... -
- CITED
-
- Close
- SHARE
-
- Close
